In breast cancer, estrogen receptor (ER) and progesterone receptor (PR) are crucial biomarkers, and their deficiency indicates the potential transformation of normal cells into cancer cells, as well as limitations in endocrine therapy and poor prognosis5–7. The gene discussed is ESR1; the disease is cancer.